Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | TYROBP |
| Upstream (Parents) |
|---|
| (<<) C1orf162 → TYROBP |
| (<<) FCER1G → TYROBP |
| (<<) HLA-DRA → TYROBP |
| (<<) CD86 → TYROBP |
| (<<) AIF1 → TYROBP |
| Downstream (Children) |
|---|
| TYROBP → TREM2 (>>) |
| TYROBP → TNFSF12-TNFSF13///TNFSF12///TNFSF13 (>>) |
| TYROBP → C1orf162 (>>) |
| TYROBP → ZPLD1 (>>) |
| TYROBP → APOC1 (>>) |
| TYROBP → MS4A4A (>>) |
| TYROBP → CD86 (>>) |
| TYROBP → LY96 (>>) |
| TYROBP → CELSR2 (>>) |
| TYROBP → VSIG4 (>>) |
| TYROBP → IGSF3 (>>) |
| TYROBP → CD14 (>>) |
| TYROBP → XPR1 (>>) |
| TYROBP → AIF1 (>>) |
| TYROBP → TRIT1 (>>) |
